IONS vs STRO
Ionis Pharmaceuticals Inc (IONS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
IONS currently screens at market cap $12.28B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the IONS and STRO stock pages for the full models.
Not investment advice.